ITM Isotopen Technologien München AG announced the lease of a new building in Neufahrn near Munich to increase production capacity of Lutetium-177 and radiopharmaceuticals. Construction has begun, with office move-in planned for autumn 2019 and production unit completion expected in 2021.
RadioMedix and ITM's subsidiary ITG signed a manufacturing and supply agreement for the production of next-generation Ge-68/Ga-68 generators at the new RadioMedix Spica Center in Houston, Texas.
Endocyte and ITM subsidiary ITG signed a long-term global supply agreement for no-carrier-added Lutetium-177 (EndolucinBeta) to support clinical and commercial supply of 177Lu-PSMA-617 through 2035. Endocyte will pay €5 million upfront to support ITM's expansion of manufacturing capacity.
| Site | Largest | Latest |
|---|---|---|
| Neufahrn near Munich, Germany | 2019-05-07 |